About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Early Limited Formula for Treating Lactation Concerns

NCT02313181·2 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

University of California, San Francisco

With

Milton S. Hershey Medical Center
HRSA/Maternal and Child Health Bureau

Age

0–0

Sex

ALL

Healthy volunteers

Accepted

You may be eligible if

1. Full term, healthy singleton infant (≥ 37 0/7 weeks gestational age) in well newborn nursery
2. Exclusively breastfeeding (has not received any feedings other than breast milk)
3. Infant is 18-72 hours old
4. Infant has weight loss of ≥75th percentile on delivery mode specific nomogram documented at 12-72 hours of age
5. English-speaking mother

You may not be if

1. Mothers or infants for whom breastfeeding is not recommended by the clinical team
2. Mothers who have already begun to produce mature breast milk
3. Any formula or water feeding prior to enrollment
4. Infants who have already lost ≥10% of their birth weight
5. Family with no active telephone number (home or cellular)
6. Plan for infant adoption or foster care
7. Mothers \<18 years of age
8. Infant receiving scoring for Narcotic Abstinence Syndrome -

The record

StatusCompleted

PhaseNo phase

Taking part328

StartedJan 2015

UpdatedMay 3, 2018

Conditions

Where2

University of California, San Francisco Medical Center
San Francisco, California, United States
Penn State Hershey Medical Center
Hershey, Pennsylvania, United States

Clareo Health | Early Limited Formula for Treating Lactation Concerns